Agenda for March 12, 2002 7:30 - 8:30 Registration and Coffee 8:30 - 8:40 Opening Remarks Rochelle Long, NIGMS 8:40 - 9:30 Keynote: Microarrays in Pharmacogenomic Studies Patrick Brown, Stanford University Pharmacogenetic Studies of Enzymes and Transporters 9:30 - 9:50 Pharmacogenetics of Membrane Transporters Kathleen M. Giacomini, University of California, San Francisco 9:50 - 10:10 Pharmacogenetics of Phase II Drug Metabolizing Enzymes Richard M. Weinshilboum, Mayo Foundation 10:10 - 10:30 Morning Coffee Break Cardiovascular and Pulmonary Pharmacogenetics 10:30 - 10:50 Pharmacogenetics Network for Cardiovascular Risk Therapy Ronald M. Krauss, Lawrence Berkeley National Laboratory 10:50 - 11:10 Pharmacogenomics of Arrhythmia Therapy Dan M. Roden, Vanderbilt University 11:10 - 11:30 Autonomic Pharmacodynamic Pharmacogenomics Daniel T. O'Connor, University of California, San Diego 11:30 - 11:50 Pharmacogenetics of Asthma Treatment Scott T. Weiss, Harvard University 11:50 - 1:00 Lunch Break 1:00 - 2:00 Keynote: Intellectual Property Issues Rebecca Eisenberg, University of Michigan Pharmacogenetic Studies in Ethnically Defined Populations 2:00 - 2:20 Pharmacogenomics and Minority Populations Mark A. Rothstein, University of Louisville School of Medicine 2:20 - 2:40 Anti-depressants in Mexican American Populations Julio Licinio, University of California, Los Angeles Knowledge Base 2:40 - 3:00 Design and Implementation of Special Databases Prakash M. Nadkarni, Yale University 3:00 - 3:30 PharmGKB Russ B. Altman, Stanford University 3:30 - 4:00 Afternoon Coffee Break Cancer Pharmacogenetics 4:00 - 4:20 Pharmacogenetics of Anticancer Agents Mark J. Ratain, University of Chicago 4:20 - 4:40 Specific Estrogen Receptor Modulator Pharmacogenetics David A. Flockhart, University of Indiana 4:40 - 5:00 Functional Polymorphism Analysis in Drug Pathways Howard L. McLeod, Washington University